CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 353 enrolled
Drug / intervention
Smartphone application +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02756949
NCT02756949N/ACompleted

Do Smartphones Increase Linkage to and Retention in Care in Newly Diagnosed HIV-positive Patients in Johannesburg, South Africa: A Multisite Randomised Controlled Trial

World Bank·interventional·Posted Apr 29, 2016·Updated Oct 24, 2019

In Brief

A clinical study evaluating Smartphone application and Smartphone for HIV Infections and 4 related conditions. Completed, enrolled 353 participants across 1 site.

Detailed Summary

This randomized controlled trial evaluates the provision of individual patient laboratory results to newly diagnosed HIV positive smartphone users through a secure application (app) as a method to get them linked to and retained in care, and engage with educational materials purposefully developed to explain their results. Message prompts will also be used to alert patients that their results are ready and provide information on how to link to care, and assistance to re-link to care if they fall out of the health system for any reason. Prompts will be sent to patients to remind health care workers if they are due for repeat laboratory monitoring. The primary endpoint is linkage to care (a HIV-related laboratory test) at 6 months. The control group received standard of care.

Study Details

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 29, 2016
Enrollment StartOct 1, 2015
Primary CompletionFeb 1, 2017
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.2 years ago

Interventions

Smartphone applicationother

Laboratory result data will be presented in the app with simple explanations on every screen. English and Zulu languages will be offered in the same app and written at a grade 4 reading level (as per WHO guidelines on literacy). Laboratory results will be supplemented with informative and relevant information explaining the result that has been shown and the recommended action for the patient to take. Patients will also be able to view additional HIV-related information and a Frequently Asked Questions (FAQ) through the app.

Smartphonedevice